Measurement of interferon-gamma by high-throughput fluorometric microvolume assay technology system.
Interferon gamma (IFN-gamma) has various immunoregulatory effects and its measurement is widely used for monitoring immune response in many clinical trials for cancer vaccines. In this study, we developed a fluorescent-linked immunosorbent assay (FLISA) for the measurement of IFN-gamma. The FLISA can accurately measure IFN-gamma concentrations and the linear dynamic range of standard curve is 15.6-2000 pg/ml (2.1 log range). Because the FLISA needs only a small amount of antibodies and there is no washing process, it is able to reduce hands-on time and running costs compared with traditional enzyme-linked immunosorbent assay (ELISA). The FLISA can be readily performed in both 96- and 384-well plates, and up to 60 plates can be handled automatically by a robotic arm. Measurement of IFN-gamma by fluorometric microvolume assay technology (FMAT) may be a high-throughput screening method for a large number of samples.
Komatsu
Nobukazu
N
Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy, Japan. kom@med.kurume-u.ac.jp
Shichijo
Shigeki
S
Maeda
Yoshiaki
Y
Itoh
Kyogo
K
D000818:Animals; D003365:Costs and Cost Analysis; D005470:Fluorometry / Q000191:economics / Q000379:methods*; D006801:Humans; D007371:Interferon-gamma / Q000032:analysis*; D051379:Mice; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D007371:Interferon-gamma